Amulet Capital Partners LP, a Greenwich-based middle-market private equity investment firm focused exclusively on the health care sector, has acquired Alliance Clinical Network (ACN), a clinical site platform.
ACN is headquartered in Dallas and owns and operates six clinical research sites serving patients, leading pharmaceutical sponsors and contract research organizations across California, Nevada and Texas. With a focus on Phase II and Phase III general medicine trials and a demonstrated expertise in enrolling diverse patient populations, ACN services a range of clinical therapeutic areas, including dermatology, gastroenterology, neurology, pain, vaccines and women”™s health.
The financial terms of the transaction were not disclosed. ACN will continue to be led by its founder and CEO Anthony Abey.
“For prominent sponsors, ACN”™s scalable, technology-driven approach has established the platform as a partner of choice with exceptional on-site expertise and a patient-centric focus that consistently drives successful outcomes,” said Nick Amigone, partner at Amulet. “We see a tremendous opportunity to grow and expand the platform and the exceptional team Anthony has built to position the business for long-term success. We look forward to working together to continue delivering high-quality results that exceed the expectations of our sponsor and CRO clients, while providing opportunities for a diverse set of patients to participate in clinical research.”
